Dudediligence.

NeOnc Technologies Holdings, Inc

NTHINASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$20,000Dec ’24$39,990Mar ’25$0.00Dec ’25$0.00Jun ’26
Net income, by quarter
−$2.2MSep ’24−$2.3MDec ’24−$32.3MMar ’25−$5.7MJun ’25−$8.6MSep ’25−$15.5MDec ’25−$8.8MMar ’26−$14.2MJun ’26
Fiscal years, by the month each ended
LineDec 2023Dec 2024Dec 2025
Revenuenone on file$83,000$39,990
Operating incomenone on file−$7.1M−$58.2M
Net incomenone on file−$11.9M−$62.1M
Operating cash flownone on file−$4.2M−$20.4M
Free cash flownone on filenone on file−$20.9M
Cash$31,862$64,893$58,729
Shares outstandingnone on file18.1M22.0M